Stay Updated
Press Releases
WASHINGTON, D.C. — The following statement was issued by Merith Basey, executive director of Patients For Affordable Drugs, in response to Eli Lilly and Company’s announcement to lower some of the company’s insulin prices by 70% and cap out-of-pocket costs at $35 per month: “Eli Lilly’s new insulin prices and caps will deliver long-awaited relief […]
Press Releases
ICYMI: Q&A With P4AD’s Executive Director Merith Basey
WASHINGTON, D.C. — Merith Basey, P4AD’s new executive director, fielded questions from P4AD’s patient community in a virtual Q&A yesterday. The forum was moderated by New Jersey patient advocate Lisa Ann Wetzel-Trainor, who lives with PTSD, fibromyalgia, and ADHD, and has been a strong advocate with P4AD for years. Over the past few weeks, patient advocates in 34 states submitted over […]
Press Releases
WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder and president of Patients For Affordable Drugs, in response to the pricing of Relyvrio following the Food and Drug Administration’s approval of the drug combination to treat amyotrophic lateral sclerosis (ALS): “The price of the newly approved drug combination […]
Press Releases
Merith Basey Named Executive Director Of Patients For Affordable Drugs
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients WASHINGTON, D.C. — Merith Basey, MSc, has been named executive director of the bipartisan advocacy organization, Patients For Affordable Drugs and its sister organization Patients For Affordable Drugs Now. Basey arrives at […]
Press Releases
In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients WASHINGTON, D.C. — The pharmaceutical industry raised prices again in July, bringing the total number of price hikes for the first seven months of this year to 1,186, exceeding the number from the […]
Press Releases
P4AD’s Report Examines BMS/Pfizer’s Eliquis And Johnson & Johnson’s Xarelto; Underscores Urgent Need For Drug Pricing Reform WASHINGTON, D.C. — A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep, harming patients and costing Medicare billions of dollars. The report prepared by Patients For Affordable […]
Press Releases
JANUARY PRICE HIKES 2.0: Big Pharma Pushes Blockbuster Prices To New Heights
Patients For Affordable Drugs’ Price Hikes Update Underscores Urgent Need For Drug Pricing Reform WASHINGTON, D.C. — As Big Pharma continued to raise prices through January, Patients For Affordable Drugs released a new report today examining the most consequential price hikes taken by the drug industry on blockbuster products during the second half of the month. Since P4AD’s […]
Press Releases
JANUARY 2022 PRICE HIKES REPORT: A New Year Brings The Same Old Bad Behavior By Big Pharma
Patients For Affordable Drugs’ Report Underscores Urgent Need For Drug Pricing Reform WASHINGTON, D.C. — As the pharmaceutical industry ushers in the new year with widespread price hikes on hundreds of life-saving and life-sustaining medications, Patients For Affordable Drugs released a new report today that takes a closer look at the 554 price hikes so far this month, […]